Front Desk: 469-391-0070

Docetaxel Chemotherapy: Uses, Dosage, and Side Effects Explained
Summary of Key Points
Docetaxel is a chemotherapy drug used to treat various cancers, including breast, lung, prostate, and gastric cancers. It works by inhibiting the growth of cancer cells. Docetaxel is typically administered as an intravenous infusion under medical supervision. Since it can cause side effects, it’s important to discuss your treatment plan with your doctor. You can also consult one of our telemedicine providers for personalized advice regarding your Docetaxel treatment.
Names of Medication
US Brand Name: Taxotere (Docetaxel)
The generic name refers to the drug’s active ingredient, listed in parentheses. Generic names describe the drug’s chemical composition, while brand names are created by the company marketing the drug.
Pharmacologic Category
Docetaxel belongs to the following pharmacologic categories:
- Paclitaxel
- Cabazitaxel
- Nab-paclitaxel
Docetaxel Dosing
Docetaxel is used to treat several types of cancer in adults, with dosing varying based on the type of cancer. Always consult your doctor before making any changes to your dose. You can also speak with one of our telemedicine providers for guidance on your Docetaxel chemotherapy regimen.
- Breast Cancer: 60-100 mg/m² intravenously every 3 weeks.
- Non-Small Cell Lung Cancer: 75 mg/m² intravenously every 3 weeks.
- Prostate Cancer: 75 mg/m² intravenously every 3 weeks, combined with prednisone.
- Gastric Cancer: 75 mg/m² intravenously every 3 weeks, combined with cisplatin and fluorouracil.
- Head and Neck Cancer: 75 mg/m² intravenously every 3 weeks, combined with cisplatin and fluorouracil.
- Esophageal Cancer: 75 mg/m² intravenously every 3 weeks, combined with cisplatin and fluorouracil.
- Bladder Cancer: 75 mg/m² intravenously every 3 weeks, combined with cisplatin.
- Ovarian Cancer: 60-75 mg/m² intravenously every 3 weeks.
- Testicular Cancer: 75 mg/m² intravenously every 3 weeks, combined with cisplatin and ifosfamide.
- Thymic Cancer: 75 mg/m² intravenously every 3 weeks, combined with cisplatin and fluorouracil.
Dosage Forms and Strengths
Docetaxel is available in the following dosage forms and strengths:
- Injection: 20 mg/1 mL (single-dose vial)
- Injection: 80 mg/4 mL (single-dose vial)
- Injection: 160 mg/8 mL (single-dose vial)
Administration Instructions for Docetaxel
Docetaxel is administered as an intravenous (IV) infusion, typically in a hospital or clinic setting. The infusion usually takes about 1 hour. Your healthcare provider will determine the appropriate dose based on your body size and the type of cancer being treated. It’s crucial to follow all instructions provided by your healthcare team to ensure the best possible outcome. If you have any questions about your Docetaxel chemotherapy regimen, you can consult one of our telemedicine providers for more information.
Adverse Reactions and Docetaxel Side Effects
Like all chemotherapy drugs, Docetaxel can cause side effects. Some are common, while others are rare but more serious. Always inform your healthcare provider if you experience any side effects. Below are some potential side effects of Docetaxel:
Common Side Effects
- Hair loss: Temporary hair thinning or loss is common.
- Nausea and vomiting: You may feel nauseous, but medications can help manage this.
- Fatigue: Feeling unusually tired is a frequent side effect.
- Low white blood cell count (neutropenia): This can increase your risk of infections.
Less Common Side Effects
- Peripheral neuropathy: Tingling or numbness in your hands and feet.
- Fluid retention: Swelling in your hands, feet, or face.
- Allergic reactions: Rash, itching, or difficulty breathing may occur during or after the infusion.
Serious Side Effects (Rare)
- Severe infections: Due to a low white blood cell count, you may be more prone to serious infections.
- Severe allergic reactions: Difficulty breathing, facial swelling, or a severe rash requires immediate medical attention.
Contraindications for Docetaxel
A contraindication is a specific situation where a medication should not be used because it may cause harm. For Docetaxel, several conditions or factors make it unsafe. If any of the following apply to you, discuss them with your healthcare provider before starting treatment with Docetaxel.
- Severe liver impairment: Docetaxel is processed by the liver. If your liver isn’t functioning properly, the medication can accumulate to dangerous levels, increasing the risk of severe side effects.
- Low white blood cell count (neutropenia): Docetaxel can further reduce your white blood cell count, increasing the risk of serious infections. If you already have a low count, this could be life-threatening.
- Severe allergic reactions to Docetaxel or polysorbate 80: Some patients may experience severe allergic reactions to Docetaxel or one of its ingredients, polysorbate 80. If you’ve had a reaction in the past, you should not take this medication.
- Pregnancy: Docetaxel can harm an unborn baby. It is contraindicated in pregnant women unless the benefits outweigh the risks, which is rare.
- Breastfeeding: Docetaxel can pass into breast milk and may harm a nursing infant. It is contraindicated during breastfeeding.
Drug to Drug Interactions with Docetaxel
Docetaxel, a chemotherapy drug, can interact with other medications, potentially increasing side effects or reducing the effectiveness of either Docetaxel or the other drugs. It is crucial to inform your healthcare provider about all medications you are taking, including over-the-counter drugs, supplements, and herbal products. Below are some common medications that may interact with Docetaxel:
- Ketoconazole (Nizoral): This antifungal medication can raise Docetaxel levels in your body, increasing the risk of side effects.
- Ritonavir (Norvir): Used to treat HIV, this drug can also elevate Docetaxel levels in your blood.
- Carbamazepine (Tegretol): This anti-seizure medication may reduce Docetaxel’s effectiveness by speeding up its breakdown in the liver.
- Phenytoin (Dilantin): Another anti-seizure medication that can lower Docetaxel’s effectiveness.
- St. John’s Wort: This herbal supplement can decrease Docetaxel’s effectiveness by accelerating its breakdown in the liver.
Docetaxel in Pregnancy
Is it Safe to Take Docetaxel During Pregnancy?
No, Docetaxel is not considered safe during pregnancy. This chemotherapy drug can harm an unborn baby, potentially causing birth defects or miscarriage. If you are pregnant or planning to become pregnant, you should avoid Docetaxel unless your healthcare provider determines that the benefits outweigh the risks, which is rare. If you are of childbearing age, it’s essential to use effective birth control while taking Docetaxel and for a period after treatment. Discuss your options with your healthcare provider.
Docetaxel While Breastfeeding
Is it Safe to Take Docetaxel While Breastfeeding?
No, Docetaxel is not safe during breastfeeding. This chemotherapy drug can pass into breast milk and may harm your baby. If you are breastfeeding, you will need to stop before starting Docetaxel treatment. Speak with your healthcare provider about alternative feeding options during your treatment.
Estimated Cost of Docetaxel
The cost of Docetaxel varies depending on location, pharmacy, and insurance coverage. Without insurance, the estimated cost for a 30-day supply using a GoodRX coupon ranges from $100 to $300. Prices may fluctuate, so it’s advisable to check with your pharmacy or use a prescription discount service like GoodRX for the most accurate pricing.
Possible Alternatives to Docetaxel
If Docetaxel is not suitable for you due to contraindications, side effects, or personal preference, there are alternative cancer treatment options for many of the conditions it treats. Always consult your healthcare provider or a telemedicine provider before making any changes to your treatment plan.
- Breast cancer: Alternatives include other chemotherapy drugs like paclitaxel (Taxol), hormone therapy, targeted therapies such as trastuzumab (Herceptin), or lifestyle changes like diet and exercise to support overall health.
- Non-small cell lung cancer: Alternatives include chemotherapy agents like cisplatin or carboplatin, targeted therapies, immunotherapy, and smoking cessation for smokers.
- Prostate cancer: Hormone therapy, radiation therapy, and chemotherapy drugs like cabazitaxel (Jevtana) are alternatives. Lifestyle changes, such as a healthy diet and regular exercise, can also be beneficial.
- Gastric cancer: Alternatives include chemotherapy agents like fluorouracil or capecitabine (Xeloda), targeted therapies, and surgery in some cases.
- Head and neck cancer: Radiation therapy, surgery, and chemotherapy drugs like cisplatin may be used as alternatives. Avoiding tobacco and alcohol can also improve outcomes.
- Esophageal cancer: Alternatives include radiation therapy, surgery, and chemotherapy drugs like fluorouracil or cisplatin.
- Bladder cancer: Alternatives include surgery, immunotherapy, and chemotherapy drugs like gemcitabine (Gemzar) or cisplatin.
- Ovarian cancer: Alternatives include chemotherapy drugs like carboplatin or paclitaxel, targeted therapies, and surgery.
- Testicular cancer: Alternatives include chemotherapy drugs like cisplatin or etoposide, radiation therapy, and surgery.
- Thymic cancer: Alternatives include surgery, radiation therapy, and chemotherapy drugs like cisplatin or cyclophosphamide.
Recent Updates on Docetaxel Research
Recent research on Docetaxel focuses on improving its effectiveness and reducing side effects. One area of study is combining Docetaxel with immunotherapy drugs, which has shown promise in treating cancers like non-small cell lung cancer and prostate cancer. Researchers are also exploring the use of lower doses of Docetaxel in combination with other treatments to reduce side effects while maintaining effectiveness.
Ongoing clinical trials are investigating new ways to deliver Docetaxel, such as nanoparticle formulations, which may improve absorption and reduce toxicity. While these studies are in early stages, they offer hope for making Docetaxel a safer and more effective cancer treatment in the future.